vs

Side-by-side financial comparison of BayCom Corp (BCML) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $21.1M, roughly 1.2× Medirom Healthcare Technologies Inc.). BayCom Corp runs the higher net margin — 26.5% vs -21.3%, a 47.8% gap on every dollar of revenue. BayCom Corp produced more free cash flow last quarter ($30.1M vs $-2.4K).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

BCML vs MRM — Head-to-Head

Bigger by revenue
BCML
BCML
1.2× larger
BCML
$25.9M
$21.1M
MRM
Higher net margin
BCML
BCML
47.8% more per $
BCML
26.5%
-21.3%
MRM
More free cash flow
BCML
BCML
$30.1M more FCF
BCML
$30.1M
$-2.4K
MRM

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
BCML
BCML
MRM
MRM
Revenue
$25.9M
$21.1M
Net Profit
$6.9M
$-4.5M
Gross Margin
10.8%
Operating Margin
36.6%
-28.5%
Net Margin
26.5%
-21.3%
Revenue YoY
9.4%
Net Profit YoY
12.1%
EPS (diluted)
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
MRM
MRM
Q4 25
$25.9M
Q3 25
$25.7M
Q2 25
$24.7M
$21.1M
Q1 25
$24.3M
Q4 24
$23.7M
Q3 24
$25.6M
Q2 24
$23.8M
Q1 24
$24.5M
Net Profit
BCML
BCML
MRM
MRM
Q4 25
$6.9M
Q3 25
$5.0M
Q2 25
$6.4M
$-4.5M
Q1 25
$5.7M
Q4 24
$6.1M
Q3 24
$6.0M
Q2 24
$5.6M
Q1 24
$5.9M
Gross Margin
BCML
BCML
MRM
MRM
Q4 25
Q3 25
Q2 25
10.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BCML
BCML
MRM
MRM
Q4 25
36.6%
Q3 25
26.3%
Q2 25
35.3%
-28.5%
Q1 25
31.6%
Q4 24
34.2%
Q3 24
32.4%
Q2 24
31.9%
Q1 24
33.3%
Net Margin
BCML
BCML
MRM
MRM
Q4 25
26.5%
Q3 25
19.5%
Q2 25
25.8%
-21.3%
Q1 25
23.4%
Q4 24
25.9%
Q3 24
23.5%
Q2 24
23.6%
Q1 24
24.0%
EPS (diluted)
BCML
BCML
MRM
MRM
Q4 25
$0.63
Q3 25
$0.46
Q2 25
$0.58
Q1 25
$0.51
Q4 24
$0.55
Q3 24
$0.54
Q2 24
$0.50
Q1 24
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$338.6M
$1.6M
Total Assets
$2.6B
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
MRM
MRM
Q4 25
Q3 25
Q2 25
$252.3K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
BCML
BCML
MRM
MRM
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BCML
BCML
MRM
MRM
Q4 25
$338.6M
Q3 25
$334.3M
Q2 25
$330.6M
$1.6M
Q1 25
$329.3M
Q4 24
$324.4M
Q3 24
$321.7M
Q2 24
$315.3M
Q1 24
$314.2M
Total Assets
BCML
BCML
MRM
MRM
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.6B
$52.0M
Q1 25
$2.6B
Q4 24
$2.7B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
$2.6B
Debt / Equity
BCML
BCML
MRM
MRM
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
MRM
MRM
Operating Cash FlowLast quarter
$31.8M
$-2.3K
Free Cash FlowOCF − Capex
$30.1M
$-2.4K
FCF MarginFCF / Revenue
116.2%
-0.0%
Capex IntensityCapex / Revenue
6.7%
0.0%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
MRM
MRM
Q4 25
$31.8M
Q3 25
$7.3M
Q2 25
$6.4M
$-2.3K
Q1 25
$9.3M
Q4 24
$30.4M
Q3 24
$9.6M
Q2 24
$7.7M
Q1 24
$5.1M
Free Cash Flow
BCML
BCML
MRM
MRM
Q4 25
$30.1M
Q3 25
$6.2M
Q2 25
$5.6M
$-2.4K
Q1 25
$9.1M
Q4 24
$28.7M
Q3 24
$9.4M
Q2 24
$7.4M
Q1 24
$3.9M
FCF Margin
BCML
BCML
MRM
MRM
Q4 25
116.2%
Q3 25
24.3%
Q2 25
22.8%
-0.0%
Q1 25
37.6%
Q4 24
121.1%
Q3 24
36.6%
Q2 24
31.2%
Q1 24
16.1%
Capex Intensity
BCML
BCML
MRM
MRM
Q4 25
6.7%
Q3 25
4.3%
Q2 25
3.0%
0.0%
Q1 25
0.6%
Q4 24
7.2%
Q3 24
1.0%
Q2 24
1.0%
Q1 24
4.7%
Cash Conversion
BCML
BCML
MRM
MRM
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCML
BCML

Segment breakdown not available.

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons